{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:46:42Z","timestamp":1782722802829,"version":"3.54.5"},"reference-count":28,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Med Insights Case Rep"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Infectious diseases exert systemic effects beyond localized inflammation, yet selective disruption of host metabolic pathways remains incompletely characterized. Carnitine-dependent fatty-acid transport is essential for mitochondrial energy production, and acquired deficiencies are rarely attributed to infection. Chronic bacteremia has not been clearly linked to functional impairment of this pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation<\/jats:title>\n                    <jats:p>\n                      A 34-year-old man with no prior metabolic or neuromuscular disease presented with subacute proximal muscle weakness, fasting intolerance, and episodic confusion following several weeks of constitutional symptoms. Evaluation demonstrated hypoketotic hypoglycemia (plasma glucose 46\u201354 mg\/dL with \u03b2-hydroxybutyrate &lt;0.3 mmol\/L), elevated creatine kinase (peak 2,140 U\/L), and reduced plasma free carnitine (12 \u03bcmol\/L; reference 25\u201350 \u03bcmol\/L), indicating impaired mitochondrial fatty-acid transport. Serial blood cultures isolated\n                      <jats:italic toggle=\"yes\">Achromobacter xylosoxidans<\/jats:italic>\n                      , confirming persistent bacteremia. Alternative endocrine, metabolic, and immunologic causes were excluded.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Resolution of metabolic abnormalities following targeted antimicrobial therapy supports an acquired and reversible disruption of fatty-acid transport. Potential mechanisms include inflammation-mediated renal carnitine loss and host\u2013pathogen metabolic competition during prolonged bacteremia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Chronic\n                      <jats:italic toggle=\"yes\">Achromobacter xylosoxidans<\/jats:italic>\n                      bacteremia may be associated with reversible secondary carnitine deficiency and selective impairment of fatty-acid transport. Plasma free carnitine normalized after antimicrobial therapy and short-term L-carnitine supplementation, with no recurrence during six months of follow-up. Metabolic evaluation should be considered in patients with unexplained hypoketotic hypoglycemia and persistent bloodstream infection.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11795476261465063","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:51:40Z","timestamp":1782553900000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reversible Secondary Carnitine Deficiency Associated With Chronic\n                    <i>Achromobacter xylosoxidans<\/i>\n                    Bacteremia Presenting as Acute Metabolic Myopathy: A Case Report"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2499-4874","authenticated-orcid":false,"given":"Amogh","family":"Verma","sequence":"first","affiliation":[{"name":"Rama Medical College Hospital & Research Centre"},{"name":"Medicos In Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip Kumar","family":"Kakru","sequence":"additional","affiliation":[{"name":"School of Medical Sciences and Research"},{"name":"Sharda University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotina","family":"Shridevi","sequence":"additional","affiliation":[{"name":"Malla Reddy Vishwavidyapeeth"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana","family":"Roy","sequence":"additional","affiliation":[{"name":"Dr. D. Y. Patil Vidyapeeth (Deemed-to-be-University)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Puri","sequence":"additional","affiliation":[{"name":"Graphic Era Hill University"},{"name":"Graphic Era Deemed University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Verma","sequence":"additional","affiliation":[{"name":"Noida Institute of Engineering & Technology (Pharmacy Institute)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrin Reneus","family":"Paul","sequence":"additional","affiliation":[{"name":"Saveetha University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorabh","family":"Lakhanpal","sequence":"additional","affiliation":[{"name":"Lovely Professional University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[{"name":"Chitkara University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakasini","family":"Satapathy","sequence":"additional","affiliation":[{"name":"Chandigarh University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"e_1_3_9_2_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13211789"},{"key":"e_1_3_9_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155267"},{"key":"e_1_3_9_4_2","doi-asserted-by":"publisher","DOI":"10.22270\/ujpr.v9i5.1201"},{"key":"e_1_3_9_5_2","doi-asserted-by":"publisher","unstructured":"Muniz-Santos R Lucieri-Costa G Almeida M et al. Lipid oxidation dysregulation: an emerging player in the pathophysiology of sepsis. Front Immunol. 2023; 14: doi:10.3389\/fimmu.2023.1224335.","DOI":"10.3389\/fimmu.2023.1224335"},{"key":"e_1_3_9_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30087"},{"key":"e_1_3_9_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-018-1581-3"},{"key":"e_1_3_9_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01880631"},{"key":"e_1_3_9_9_2","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20193400"},{"key":"e_1_3_9_10_2","doi-asserted-by":"publisher","unstructured":"Bayless DR Dumais MG McHugh JW et al. Clinical and microbiologic features of Achromobacter species: a 10-year multicenter experience. J Clin Microbiol. 63: doi:10.1128\/jcm.00724-25 Epub ahead of print 8 October 2025","DOI":"10.1128\/jcm.00724-25"},{"key":"e_1_3_9_11_2","doi-asserted-by":"publisher","unstructured":"Bonis BM Hunter RC. JMM Profile: Achromobacter xylosoxidans: the cloak-and-dagger opportunist. J Med Microbiol. 71: doi:10.1099\/jmm.0.001505 Epub ahead of print 31 May 2022","DOI":"10.1099\/jmm.0.001505"},{"key":"e_1_3_9_12_2","doi-asserted-by":"publisher","DOI":"10.7453\/gahmj.2013.008"},{"key":"e_1_3_9_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09568-3"},{"key":"e_1_3_9_14_2","doi-asserted-by":"publisher","unstructured":"Farf\u00e1n-Cano G Silva-Rojas GA. Achromobacter xylosoxidans as emerging pathogen in healthcare settings: A mini review. Narra X. 1: doi:10.52225\/narrax.v1i1.74 Epub ahead of print 30 April 2023","DOI":"10.52225\/narrax.v1i1.74"},{"key":"e_1_3_9_15_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.91935"},{"key":"e_1_3_9_16_2","doi-asserted-by":"publisher","DOI":"10.4322\/acr.2017.029"},{"key":"e_1_3_9_17_2","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.1258"},{"key":"e_1_3_9_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2012.142"},{"key":"e_1_3_9_19_2","doi-asserted-by":"publisher","DOI":"10.12701\/yujm.2019.00276"},{"key":"e_1_3_9_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12863-014-0090-y"},{"key":"e_1_3_9_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052719"},{"key":"e_1_3_9_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom14040392"},{"key":"e_1_3_9_23_2","first-page":"103","article-title":"Exploratory Analysis of TLR2, TLR4, Interleukin 6 and Interleukin 10 Gene Polymorphisms in Relation to Clinical Early-Onset Sepsis","volume":"16","author":"Baizat M","year":"2026","unstructured":"Baizat M, Iancu M, Zaharie G, et al. Exploratory Analysis of TLR2, TLR4, Interleukin 6 and Interleukin 10 Gene Polymorphisms in Relation to Clinical Early-Onset Sepsis. Preterm Neonates: A Single-Center Study. 2026;16:103.","journal-title":"Preterm Neonates: A Single-Center Study"},{"key":"e_1_3_9_24_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1239"},{"key":"e_1_3_9_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/trz016"},{"key":"e_1_3_9_26_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268816001564"},{"key":"e_1_3_9_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclepro.2022.134632"},{"key":"e_1_3_9_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-024-02089-z"},{"key":"e_1_3_9_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05069-w"}],"container-title":["Clinical Medicine Insights: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11795476261465063","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11795476261465063","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11795476261465063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:16:12Z","timestamp":1782720972000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11795476261465063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":28,"alternative-id":["10.1177\/11795476261465063"],"URL":"https:\/\/doi.org\/10.1177\/11795476261465063","relation":{},"ISSN":["1179-5476","1179-5476"],"issn-type":[{"value":"1179-5476","type":"print"},{"value":"1179-5476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"article-number":"11795476261465063"}}